Evidence map›Paper›PMID 39741851›Full record

ArticleACS omega2024

Bidirectional Modulation on Electroporation Induced by Membrane Tension Under the Electric Field.

Ping Ye, Lulu Huang, Kuiwen Zhao

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evaluation of Small-Molecule Candidates as Modulators of M-Type KInternational journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ping YeSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 20093, China.
Lulu HuangSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 20093, China.ORCID https://orcid.org/0009-0007-1761-5481
Kuiwen ZhaoSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 20093, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electroporation ablation is a minimally invasive nonthermal ablation technology that is applied to tumor ablation therapy. Given the varied morphologies of tumor cells, when an electric field is applied to the cell membrane surface, the direction of the electric field produces various angles with normal to the tangential plane of the cell membrane. In this study, we investigated the impact of cell morphology on membrane electroporation characteristics by adjusting the angle of the electric field relative to the cell membrane by using molecular dynamics simulations. The results show that the bidirectional modulation of cell membrane surface tension induced by Coulomb force can be triggered, allowing the electroporation effect to be regulated, by varying the angle between the electric field direction and the normal to the membrane. Electric field angles below 45° decreased phospholipid membrane surface tension, facilitating pore formation; angles above 45° enhanced the surface tension, elevating the energy barrier for pore opening and thus inhibiting pore formation. Furthermore, during the initial stage of membrane pore formation, water molecules penetrated the lipids, which aligned with the electric field and affected the pore tilt. The bidirectional modulation of the electric field in electroporation demonstrated that reversing the angle of the electric field is a potentially effective electroporation ablation protocol for improving the effectiveness of clinical cancer treatments.

Identifiers

PMID39741851
PMCPMC11683631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.